Literature DB >> 9849489

8-chloroadenosine 3',5'-monophosphate (8-Cl-cAMP) selectively eliminates protein kinase A type I to induce growth inhibition in c-ras-transformed fibroblasts.

K Noguchi1, T Murata, Y S Cho-Chung.   

Abstract

8-Chloroadenosine 3',5'-monophosphate (8-Cl-cAMP), a site-selective cyclic adenosine 3',5'-monophosphate (cAMP) analogue, exhibits growth inhibition in a broad spectrum of cancer cell lines. We investigated the effect of 8-Cl-cAMP on c-ras-transformed mouse fibroblasts (MP3/3T3) which were established by transfection of Balb3T3 cells (Balb3T3) with the point-mutated c-ras gene [G12-->V12]. 8-Cl-cAMP (2-5 microM) exerted over 80% growth inhibition by day 4 on MP3/3T3, while inhibiting parental Balb3T3 cell growth less than 40%. In order to distinguish the effect of 8-Cl-cAMP from that of 8-chloroadenosine (8-Cl-adenosine), we examined the effect of 8-Cl-cAMP in serum-free medium. 8-Cl-cAMP demonstrated a potent growth inhibition of MP3/3T3 cells cultured in serum-free medium, suggesting that the growth inhibitory effect of 8-Cl-cAMP was not due to its hydrolysed product, 8-Cl-adenosine. In addition, both Balb3T3 and MP3/3T3 contained cAMP phosphodiesterases mainly composed of isozyme IV which has previously been reported to be insensitive towards the hydrolysis of 8-Cl-cAMP. Non-transformed Balb3T3 cells contained only type II cAMP-dependent protein kinase (PKA), whereas transformed MP3/3T3 exhibited a marked increase in type I PKA. The growth inhibition of MP3/3T3 by 8-Cl-cAMP accompanied almost complete elimination of type I PKA without affecting type II PKA. Moreover, 8-Cl-cAMP induced an arrest in the G0/G1-phase of the cell cycle in MP3/3T3. 8-Cl-adenosine had little or no effect on the cell cycle kinetics of MP3/3T3 cells. These results show that 8-Cl-cAMP is a novel cAMP analogue which selectively eliminates type I PKA to induce growth inhibition in transformed fibroblasts.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9849489     DOI: 10.1016/s0959-8049(98)00051-3

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  8 in total

1.  8-Cl-adenosine-induced inhibition of colorectal cancer growth in vitro and in vivo.

Authors:  C C Carlson; R Chinery; L L Burnham; D T Dransfield
Journal:  Neoplasia       Date:  2000 Sep-Oct       Impact factor: 5.715

2.  8-Cl-adenosine induces differentiation in LS174T cells.

Authors:  C C Carlson; L L Burnham; R A Shanks; D T Dransfield
Journal:  Dig Dis Sci       Date:  2001-04       Impact factor: 3.199

3.  A study on the genotoxic effects of 8-Cl-cAMP on human lymphocytes in vitro.

Authors:  V Bajić; N Djelić; B Spremo-Potparević; L Zivković; Z Milićević
Journal:  Genetika       Date:  2008-05

4.  E2F1-mediated DNA damage is implicated in 8-Cl-adenosine-induced chromosome missegregation and apoptosis in human lung cancer H1299 cells.

Authors:  Yu-Ying Han; Zhe Zhou; Ji-Xiang Cao; Ya-Qiong Jin; Shu-Yan Li; Ju-Hua Ni; Guo-Shun An; Yu-Xiang Zhang; Hong-Ti Jia
Journal:  Mol Cell Biochem       Date:  2013-09-15       Impact factor: 3.396

5.  8-Cl-cAMP antagonizes mitogen-activated protein kinase activation and cell growth stimulation induced by epidermal growth factor.

Authors:  A Budillon; E Di Gennaro; M Caraglia; D Barbarulo; A Abbruzzese; P Tagliaferri
Journal:  Br J Cancer       Date:  1999-12       Impact factor: 7.640

6.  Triple negative breast cancer development can be selectively suppressed by sustaining an elevated level of cellular cyclic AMP through simultaneously blocking its efflux and decomposition.

Authors:  Wei Wang; Yue Li; Jessica Y Zhu; Dongdong Fang; Han-Fei Ding; Zheng Dong; Qing Jing; Shi-Bing Su; Shuang Huang
Journal:  Oncotarget       Date:  2016-12-27

7.  8-Cl-Adenosine enhances 1,25-dihydroxyvitamin D3-induced growth inhibition without affecting 1,25-dihydroxyvitamin D3-stimulated differentiation of primary mouse epidermal keratinocytes.

Authors:  Wendy B Bollag; Xiaofeng Zhong; Sarah Josephson
Journal:  BMC Pharmacol       Date:  2004-07-27

Review 8.  Targeting protein kinase A in cancer therapy: an update.

Authors:  Luigi Sapio; Francesca Di Maiolo; Michela Illiano; Antonietta Esposito; Emilio Chiosi; Annamaria Spina; Silvio Naviglio
Journal:  EXCLI J       Date:  2014-08-18       Impact factor: 4.068

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.